Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment